Literature DB >> 16845539

[Malaria protection for short-term travelers].

C Hatz1, H Nothdurft.   

Abstract

An average of 800 malaria cases are recorded annually in Germany. One person in a hundred dies of the disease. Travel advice given by experienced physicians is essential to raise awareness of malaria risk in endemic areas. Rational mosquito protection on skin and textiles reduces the risk of malaria and other arthropod-transmitted diseases (e. g. dengue fever). Regular intake of an antimalarial drugs to suppress the development forms the basis of reliable chemo prophylaxis in highly endemic areas. The concept of standby emergency treatment (SET) in areas of low or moderate risk needs to be communicated in a detailed and clear way: take the temperature when feeling unwell; seeing a doctor immediately if a fever arises after 6 days of stay in an area, intake of SET if a doctor can not be reached within 24 hours; see a doctor after taking the SET as quickly as possible. These elements help to reduce the rate of severe malaria cases among travelers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16845539     DOI: 10.1007/s00108-006-1653-4

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  19 in total

1.  Seroconversion to circumsporozoite antigen of Plasmodium falciparum demonstrates a high risk of malaria transmission in travelers to East Africa.

Authors:  H D Nothdurft; T Jelinek; A Blüml; F von Sonnenburg; T Löscher
Journal:  Clin Infect Dis       Date:  1999-03       Impact factor: 9.079

2.  Epidemiology of malaria in the British Army from 1982-1996.

Authors:  S A Miller; B P Bergman; A M Croft
Journal:  J R Army Med Corps       Date:  1999-02       Impact factor: 1.285

3.  Risk assessment and disease prevention in travelers visiting friends and relatives.

Authors:  Sonia Y Angell; Ron H Behrens
Journal:  Infect Dis Clin North Am       Date:  2005-03       Impact factor: 5.982

4.  Neuropsychiatric side effects after the use of mefloquine.

Authors:  T Weinke; M Trautmann; T Held; G Weber; D Eichenlaub; K Fleischer; W Kern; H D Pohle
Journal:  Am J Trop Med Hyg       Date:  1991-07       Impact factor: 2.345

5.  Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa.

Authors:  R Steffen; E Fuchs; J Schildknecht; U Naef; M Funk; P Schlagenhauf; P Phillips-Howard; C Nevill; D Stürchler
Journal:  Lancet       Date:  1993-05-22       Impact factor: 79.321

6.  Survey of use of malaria prevention measures by Canadians visiting India.

Authors:  C C dos Santos; A Anvar; J S Keystone; K C Kain
Journal:  CMAJ       Date:  1999-01-26       Impact factor: 8.262

7.  Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years.

Authors:  C Hatz; S Abdulla; R Mull; D Schellenberg; I Gathmann; P Kibatala; H P Beck; M Tanner; C Royce
Journal:  Trop Med Int Health       Date:  1998-06       Impact factor: 2.622

8.  Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study.

Authors:  Patricia Schlagenhauf; Alois Tschopp; Richard Johnson; Hans D Nothdurft; Bernhard Beck; Eli Schwartz; Markus Herold; Bjarne Krebs; Olivia Veit; Regina Allwinn; Robert Steffen
Journal:  BMJ       Date:  2003-11-08

9.  Malaria prophylaxis policy for travellers from Europe to the Indian Subcontinent.

Authors:  R H Behrens; Z Bisoffi; A Björkman; J Gascon; C Hatz; T Jelinek; F Legros; N Mühlberger; P Voltersvik
Journal:  Malar J       Date:  2006-02-01       Impact factor: 2.979

10.  Malaria risk in travelers.

Authors:  Helena Hervius Askling; Jenny Nilsson; Anders Tegnell; Ragnhild Janzon; Karl Ekdahl
Journal:  Emerg Infect Dis       Date:  2005-03       Impact factor: 6.883

View more
  1 in total

1.  Failure of malaria chemoprophylaxis with mefloquine in an oversize traveller to Mozambique.

Authors:  Federico Gobbi; Andrea Rossanese; Dora Buonfrate; Andrea Angheben; Gianluigi Lunardi; Zeno Bisoffi
Journal:  Malar J       Date:  2013-12-18       Impact factor: 2.979

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.